Thompson Alexis A. 4
4 · Global Blood Therapeutics, Inc. · Filed Mar 18, 2022
Insider Transaction Report
Form 4
Thompson Alexis A.
Director
Transactions
- Exercise/Conversion
Common Stock
2022-03-17+2,400→ 2,400 total - Exercise/Conversion
Restricted Stock Units
2022-03-17−2,400→ 4,800 total→ Common Stock (2,400 underlying)
Footnotes (2)
- [F1]Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.
- [F2]The shares of Common Stock underlying the RSUs vest in three equal annual installments after March 17, 2021, so long as the Reporting Person continues as a board member of the Issuer through each vesting date. The shares of Common Stock underlying the RSUs are subject to full acceleration of vesting with respect to all then-unvested shares upon the consummation of a Sale Event (as defined in the Issuer's 2015 Stock Option and Incentive Plan, as amended).